A detailed history of Jefferies Group LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Jefferies Group LLC holds 174 shares of PRTA stock, worth $2,738. This represents 0.0% of its overall portfolio holdings.

Number of Shares
174
Holding current value
$2,738
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$25.16 - $60.63 $4,377 - $10,549
174 New
174 $11,000
Q1 2018

May 15, 2018

SELL
$27.95 - $45.04 $218,065 - $351,402
-7,802 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$35.44 - $63.76 $276,502 - $497,455
7,802
7,802 $292,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $739M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.